Multus
Multus is a biotechnology company that provides lab-grown meat alternatives using cellular agriculture technology. The company uses cells from livestock animals to cultivate meat products without animal slaughter, providing sustainable alternatives to conventionally produced meat. Multus technology focuses on developing the growth media and bioprocessing infrastructure needed to make cultured meat production…
Funding snapshot
About
Multus is a biotechnology company that provides lab-grown meat alternatives using cellular agriculture technology. The company uses cells from livestock animals to cultivate meat products without animal slaughter, providing sustainable alternatives to conventionally produced meat. Multus technology focuses on developing the growth media and bioprocessing infrastructure needed to make cultured meat production commercially viable, addressing one of the key cost barriers in cellular agriculture. The company approach enables the production of real animal meat with significantly reduced environmental impact, eliminating the need for animal farming while providing the same nutritional and sensory qualities as conventional meat. Founded in 2019 and headquartered in London, United Kingdom, Multus has raised approximately $9.3 million in Series A funding from investors including Ukri, Mandi Ventures, SOSV, SynBioVen, and Asahi Kasei.
Business model
Genomics > Enabling Technologies > Kits and Reagents > Bioreagents,
Life Sciences Platforms and Tools > Research Reagents and Kits > Cell Culture > Growth Media
Founders & team highlights
Serial Founder
Institutional investors
Backed by funds in our directory
Latest coverage
No articles yet.
Similar startups
Immuneel
Developer of T-cell therapies for the treatment of cancer. It is developing cell therapies by using genetic engineering that modifies healthy immune cells to target cancerous cells.
ImmunoACT
Developer of cell and gene therapies for cancer treatment. It offers a lead product NexCAR19 Talicabtagene autoleucel for B‑cell malignancies such as B‑lymphoma and B‑acute lymphoblastic leukaemia.
HaystackAnalytics
EmbeDL is a provider of an edge AI optimization and deployment platform that streamlines the path from deep learning model development to hardware-ready deployment on embedded systems.
4baseCare
Sitehop is a provider of hardware-enforced network encryption solutions that delivers ultra-low latency, quantum-ready encryption for data-in-motion in critical networks through its SAFE Series product line.